Biolife Sciences (Biolife Sciences) EV-to-EBITDA : 1.74 (As of Jun. 14, 2024)

Biolife Sciences EV-to-EBITDA Chart

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
EV-to-EBITDA	Get a 7-Day Free Trial										9.36	11.59	11.62	16.37	19.31

Competitive Comparison of Biolife Sciences's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Biolife Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolife Sciences's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's EV-to-EBITDA falls into.

Biolife Sciences EV-to-EBITDA Calculation

Biolife Sciences's EV-to-EBITDA for today is calculated as:

Biolife Sciences's current Enterprise Value is $0.32 Mil.
Biolife Sciences's EBITDA for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences  (OTCPK:BLFE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biolife Sciences's PE Ratio for today is calculated as:

Biolife Sciences's share price for today is $0.0001.
Biolife Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-825.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Biolife Sciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description